Corporate & Financial Strategy
  Investor Relations
  Financial Communications

EJ Palmer Consulting

NeRRE Therapeutics

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

EJPC has worked with NeRRE Therapeutics on media relations and conference presentations.

Additional Info